Tibet Weixinkang Medicine Co Ltd Net Asset Momentum
Tibet Weixinkang Medicine Co Ltd net asset momentum. Tibet Weixinkang Medicine Co Ltd (603676) recorded a net asset momentum of 6.6% as of December 2025, with net assets of CN¥1.48 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See 603676 book value for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Tibet Weixinkang Medicine Co Ltd (2013–2025)
Net asset momentum of Tibet Weixinkang Medicine Co Ltd from 2013 to 2025. This chart tracks Tibet Weixinkang Medicine Co Ltd's year-over-year net asset growth across 13 annual reporting periods from 2013 to 2025. The most recent momentum reading is +6.6%, with net assets of CN¥1.48 Billion CNY as of December 2025. Check 603676 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Tibet Weixinkang Medicine Co Ltd Net Asset Momentum by Year (2013–2025)
Tibet Weixinkang Medicine Co Ltd net asset momentum by year from 2013 to 2025. The table below shows the complete annual net asset history for Tibet Weixinkang Medicine Co Ltd from 2013 to 2025, covering 13 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see Tibet Weixinkang Medicine Co Ltd (603676) market capitalisation.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥1.48 Billion | CN¥1.87 Billion | CN¥390.49 Million | ▲ +6.6% |
| 2024 | CN¥1.39 Billion | CN¥1.85 Billion | CN¥468.24 Million | ▲ +3.4% |
| 2023 | CN¥1.34 Billion | CN¥1.78 Billion | CN¥436.55 Million | ▲ +9.8% |
| 2022 | CN¥1.22 Billion | CN¥1.66 Billion | CN¥444.13 Million | ▲ +14.4% |
| 2021 | CN¥1.07 Billion | CN¥1.50 Billion | CN¥428.31 Million | ▲ +8.5% |
| 2020 | CN¥983.21 Million | CN¥1.36 Billion | CN¥376.85 Million | ▲ +5.7% |
| 2019 | CN¥930.05 Million | CN¥1.30 Billion | CN¥374.56 Million | ▲ +3.6% |
| 2018 | CN¥897.64 Million | CN¥1.23 Billion | CN¥337.33 Million | ▲ +4.6% |
| 2017 | CN¥858.04 Million | CN¥1.02 Billion | CN¥158.58 Million | ▲ +86.8% |
| 2016 | CN¥459.42 Million | CN¥552.36 Million | CN¥92.94 Million | ▲ +14.0% |
| 2015 | CN¥402.93 Million | CN¥508.75 Million | CN¥105.82 Million | ▲ +40.7% |
| 2014 | CN¥286.28 Million | CN¥363.37 Million | CN¥77.09 Million | ▲ +15.5% |
| 2013 | CN¥247.78 Million | CN¥309.30 Million | CN¥61.52 Million | — |